Julg B, Tartaglia LJ, Keele BF, Wagh K, Pegu A, Sok D, Abbink P, Schmidt SD, Wang K, Chen X, Joyce MG, Georgiev IS, Choe M, Kwong PD, Doria-Rose NA, Le K, Louder MK, Bailer RT, Moore PL, Korber B, Seaman MS, Abool Karim SS, Morris L, Koup RA, Mascola JR, Burton DR, Barouch DH.
Science Translational Medicine 2017; 9(406): eaal1321. DOI: 10.1126/scitranslmed.aal1321
Kufa T, Kharsany A, Cawood C, Khanyile D, Lewis L, Grobler A, Chipeta Z, Bere A, Glenshaw M, Puren A.
Journal of the International AIDS Society 2017; 20(Suppl 6):35-43.
Vandormael A, Rego F, Danaviah S, Carlos Junior Alcantara L, Boulware DR, de Oliveira T.
Current HIV Research 2017; 15(3):225-231.
Schopper D, Ravinetto R, Schwartz L, Kamaara E, Sheel S, Segelid MJ, Ahmad A, Dawson A, Singh J, Jesani A, Upshur R. .
Public Health Ethics 2017; 10(1):49-61.
Naicker N, Naidoo A, Werner L, Garrett N, Majola N, Asari V, Baxter C, Grobler A, Abdool Karim Q, Abdool Karim SS.
Antiviral Therapy 2017; 22(4):287-293.
Liebenberg L, Archary D, Sivro A, Kwon DS.
Genome Medicine 2017; 9(1):74. DOI 10.1186/s13073-017-0469-2
CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.